Your browser doesn't support javascript.
loading
Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the GBD Study 2019.
Aminorroaya, Arya; Saeedi Moghaddam, Sahar; Tavolinejad, Hamed; Aryan, Zahra; Heidari, Behnam; Ebrahimi, Hedyeh; Naderian, Mohammadreza; Shobeiri, Parnian; Ghanbari, Ali; Rezaei, Nazila; Malekpour, Mohammad-Reza; Haghshenas, Rosa; Rezaei, Negar; Larijani, Bagher; Farzadfar, Farshad.
Affiliation
  • Aminorroaya A; Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine New Haven CT USA.
  • Saeedi Moghaddam S; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
  • Tavolinejad H; Tehran Heart Center, Cardiovascular Diseases Research Institute Tehran University of Medical Sciences Tehran Iran.
  • Aryan Z; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
  • Heidari B; Kiel Institute for the World Economy Kiel Germany.
  • Ebrahimi H; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
  • Naderian M; Tehran Heart Center, Cardiovascular Diseases Research Institute Tehran University of Medical Sciences Tehran Iran.
  • Shobeiri P; Department of Medicine Rutgers New Jersey Medical School Newark NJ USA.
  • Ghanbari A; Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine Tehran University of Medical Sciences Tehran Iran.
  • Rezaei N; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
  • Malekpour MR; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
  • Haghshenas R; Tehran Heart Center, Cardiovascular Diseases Research Institute Tehran University of Medical Sciences Tehran Iran.
  • Rezaei N; Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA.
  • Larijani B; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
  • Farzadfar F; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
J Am Heart Assoc ; 13(2): e030165, 2024 Jan 16.
Article in En | MEDLINE | ID: mdl-37956220
BACKGROUND: The North Africa and Middle East (NAME) region has one of the highest burdens of ischemic heart disease (IHD) worldwide. This study reports the contemporary epidemiology of IHD in NAME. METHODS AND RESULTS: We estimated the incidence, prevalence, deaths, years of life lost, years lived with disability, disability-adjusted life years (DALYs), and premature mortality of IHD, and its attributable risk factors in NAME from 1990 to 2019 using the results of the GBD (Global Burden of Disease study 2019). In 2019, 0.8 million lives and 18.0 million DALYs were lost due to IHD in NAME. From 1990 to 2019, the age-standardized DALY rate of IHD significantly decreased by 33.3%, mostly due to the reduction of years of life lost rather than years lived with disability. In 2019, the proportion of premature death attributable to IHD was higher in NAME compared with global measures: 26.8% versus 16.9% for women and 18.4% versus 14.8% for men, respectively. The age-standardized DALY rate of IHD attributed to metabolic risks, behavioral risks, and environmental/occupational risks significantly decreased by 28.7%, 37.8%, and 36.4%, respectively. Dietary risk factors, high systolic blood pressure, and high low-density lipoprotein cholesterol were the top 3 risks contributing to the IHD burden in most countries of NAME in 2019. CONCLUSIONS: In 2019, IHD was the leading cause of death and lost DALYs in NAME, where premature death due to IHD was greater than the global average. Despite the great reduction in the age-standardized DALYs of IHD in NAME from 1990 to 2019, this region still had the second-highest burden of IHD in 2019 globally.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Myocardial Ischemia / Global Burden of Disease Limits: Adult / Female / Humans / Male Country/Region as subject: Africa / Asia Language: En Journal: J Am Heart Assoc Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Myocardial Ischemia / Global Burden of Disease Limits: Adult / Female / Humans / Male Country/Region as subject: Africa / Asia Language: En Journal: J Am Heart Assoc Year: 2024 Document type: Article